BRUKER CORPORATION (NASDAQ:BRKR) Files An 8-K Other Events
Item 8.01. Other Events.
  On May11, 2017, the Board of Directors of Bruker Corporation (the
  Company) approved a share repurchase program authorizing the
  purchase of up to $225 million of the Companys common stock over
  a two-year period commencing May12, 2017 and declared a quarterly
  cash dividend in the amount of $0.04 per share on the Companys
  common stock. The dividend will be paid on June23, 2017 to
  stockholders of record as of June5, 2017.
  Under the share repurchase program, the Company may repurchase
  its common stock from time to time, in amounts, at prices, and at
  such times as the Company deems appropriate, subject to market
  conditions, legal requirements and other considerations. The
  Companys repurchases may be executed using open market purchases,
  privately negotiated purchases or other transactions during the
  period from May12, 2017 to May11, 2019. The Company intends to
  fund repurchases under the share repurchase program from cash on
  hand and available borrowings under its existing credit facility.
  The share repurchase program does not obligate the Company to
  repurchase any specific number of shares and may be suspended,
  modified or terminated at any time without prior notice.
  A copy of the Companys press release announcing approval of the
  $225 million share repurchase program and the quarterly dividend
  payment is attached as Exhibit99.1 to this Current Report on
  Form8-K.
FORWARD-LOOKING STATEMENTS
  This report contains forward-looking statements, including, but
  not limited to, statements regarding the Companys commitment to
  repurchasing its shares at any level in the future, the
  anticipated value of shares to be repurchased by the Company, the
  expected timing of such repurchases and the availability of funds
  for the repurchase of shares. These forward-looking statements
  are based on current information and expectations, and involve a
  number of risks and uncertainties. Actual future results and/or
  events may differ materially from such expectations as a result
  of important risk factors, which include, in addition to those
  identified in the Companys Form10-K for the year ended
  December31, 2016 and its other filings with the Securities and
  Exchange Commission: a change in the Companys share repurchase
  program by the Companys Board of Directors or management,
  including changes in the value of shares to be repurchased or the
  timing of such repurchases, and unanticipated material payment
  obligations incurred by the Company that decrease the Companys
  willingness or ability to repurchase shares at the anticipated
  level and timing, or at all. These risks and uncertainties could
  cause actual results to differ materially from those referred to
  in these forward-looking statements. The Company expressly
  disclaims any obligation to update or revise these
  forward-looking statements, except as otherwise specifically
  stated by the Company or as required by law or regulation.
Section9 Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
| (d) | Exhibits | 
| Number | |
| 99.1 Press release dated May12, 2017. | 
 About BRUKER CORPORATION (NASDAQ:BRKR) 
Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive (CBRNE) detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices.	BRUKER CORPORATION (NASDAQ:BRKR) Recent Trading Information 
BRUKER CORPORATION (NASDAQ:BRKR) closed its last trading session down -0.34 at 25.33 with 490,419 shares trading hands.
 
                



